Check Arcus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
-3.708
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.36
Industry PE ratio
-3.9415151515151514
P/B Ratio
0PEG Ratio
0EBITDA
-328.0M
Revenue (TTM)
262.0M
Profit Margin
-113.74%
Return On Equity TTM
118856500.00%
Track how Arcus Biosciences Inc P/E has moved over time to understand its valuation trends.
Arcus Biosciences Inc in the last 5 years
Lowest (28.75x)
September 30, 2022
Today (-6.36x)
September 18, 2025
Industry (-3.94x)
September 18, 2025
Highest (90.21x)
December 31, 2021
Today’s Price to Earnings Ratio: -6.36x
Compare market cap, revenue, PE, and other key metrics of Arcus Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.3B | -45.17% | -6.36 | -113.74% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Arcus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arcus Biosciences Inc investment value today
Current value as on today
₹79,241
Returns
Returns from Arcus Biosciences Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 18 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Arcus Biosciences Inc. Average target price of $28.36
Get share price movements and forecasts by analysts on Arcus Biosciences Inc.
What analysts predicted
56.81%UPSIDE
Target Price
$28.36
Current Price
$12.25
Analyzed by
18 Analysts
Target
$28.36
Arcus Biosciences Inc target price $28.36, a slight upside of 56.81% compared to current price of $12.25. According to 18 analysts rating.
Search interest for Arcus Biosciences Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 26.0M → 160.0M (in $), with an average increase of 44.8% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -112.0M → -8.0M (in $), with an average increase of 1300.0% per quarter
Price Rise
In the last 7 days, RCUS stock has moved up by 4.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 165.1%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 95.4%
Organisation | Arcus Biosciences Inc |
Headquarters | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
Industry | Health Technology |
CEO | Dr. Terry J. Rosen Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Robert C. Goeltz II | Principal Financial Officer & CFO |
Ms. Jennifer A. Jarrett M.B.A. | Chief Operating Officer |
Dr. K. Christopher Garcia Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Mr. Alexander Azoy CPA | VP of Finance & Principal Accounting Officer |
Dr. Jonathan Yingling Ph.D. | Chief Scientific Officer |
Dr. Juan Carlos Jaen Ph.D. | Co- Founder & President |
Pia Eaves | Vice President of Investor Relations & Strategy |
Ms. Carolyn C. Tang J.D. | General Counsel & Corporate Secretary |
Holli Kolkey | Vice President of Corporate Communications |
Dr. Terry J. Rosen Ph.D. | Co-Founder, Chairman & CEO |
Arcus Biosciences Inc share price today is $12.25 as on . Arcus Biosciences Inc share today touched a day high of $12.38 and a low of $12.09.
Arcus Biosciences Inc share touched a 52 week high of $18.98 on and a 52 week low of $6.5 on . Arcus Biosciences Inc stock price today i.e. is trending at $12.25,which is 35.46% down from its 52 week high and 88.46% up from its 52 week low.
Arcus Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Arcus Biosciences Inc (RCUS) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Arcus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcus Biosciences Inc share’s latest price of $12.25 as on September 18, 2025 at 10:36 pm IST, you will get 0.8163 shares of Arcus Biosciences Inc. Learn more about
fractional shares .
Arcus Biosciences Inc stock has given -45.17% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?